Vanberra Signal
Free trial

IGC Pharma

Curated by Signal

Developer of cannabis-based pharmaceuticals

Health Technologyigcpharma.com

Overview

Developer of cannabis-based pharmaceuticals. The company's products include Hyalolex for Alzheimer’s disease. The company is developing cannabinoid pharmaceutical formulation for the treatment of neuropathic pain and cachexia, a condition that causes extreme weight loss and muscle wasting. Its other products include Holief to treat pain, Herbo for beauty and skincare brand, Sunday Seltzer used as a beverage, and Holi Hemp (hemp extracts). The company produces hemp-based drugs for Parkinson's disease, chronic pain and pet seizures.

Key facts

Founded
2005
Headquarters
Potomac, United States
Stage
Sign up to view
Industry
Health Technology

Contact

Primary office
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • MARIJMD

    Provider of medical marijuana card recommendation on doctor consultation

    Health TechnologyWest Palm Beach, United States

  • Cannect

    Provider of a content platform for medical cannabis dispensaries, local products, and cannabis news

    Health TechnologyAlbuquerque, United States

  • EP Studios

    Provider of mobile app for the diagnosis of cardiac arrhythmia

    Health TechnologyUnited States

About IGC Pharma

What does IGC Pharma do?

Developer of cannabis-based pharmaceuticals.

Where is IGC Pharma headquartered?

IGC Pharma is headquartered in Potomac, United States.

When was IGC Pharma founded?

IGC Pharma was founded in 2005.

Which sector is IGC Pharma in?

IGC Pharma operates in Health Technology.

Who are IGC Pharma's competitors?

Companies similar to IGC Pharma include MARIJMD, Cannect, and EP Studios.